explore -WSS

explore

author：hotspot 2025-09-30 00:50:26 - browse：7

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： FDA panel to weigh safety of artificial wombs for preterm births

WSS

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Roche's accidental data boosts hopes for anti

Wegovy improves function in certain heart failure patients

Wegovy improves function in certain heart failure patients

Roche's accidental data boosts hopes for anti

Eli Lilly CEO gives to Mike Pence presidential super PAC

focus

explore

entertainment

ChatGPT in medicine: STAT answers readers' burning questions

Information blocking fines are now fair game in health care

Trump demands the U.S. pay no more for drugs than other countries … again

Fed up with FDA, ALS advocates consider a take

Jerome Adams on the need for new antivirals for Covid

David Liu startup to focus on CRISPR delivery

After affirmative action ruling, medical educators look to 'holistic review'

The unintended consequences of overturning Roe v. Wade

Novavax promises a turnaround & Lilly roils the obesity market

Covid’s new normal has set in amid another rise in cases

focus

Chamber of Commerce, DOJ clash in court over drug prices

Transgender sports debate: Physicians say bans are health issue

David Liu startup to focus on CRISPR delivery

Health officials lay out plans to cope with respiratory virus season

Trans patients at the end of life deserve respect and dignity

Former Pear Therapeutics executives start new VC firm

hotspot

hotspot

hotspot

knowledge